Skip to content

Evaluation of necessity, safety and clinical effctiveness of unlicesed vaccine for travelers and patient in Japan.

Evaluation of necessity, safety and clinical effctiveness of unlicesed vaccine for travelers and patient in Japan. - Clinical evaluation of necessity, safety and effctiveness of unlicesed vaccine in Japan.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000011168
Enrollment
200
Registered
2013-07-11
Start date
2013-07-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Travelers and immunocopromised host who need vaccination unlicensed vaccine

Interventions

People who need unlicensed vaccine for travel or underlying disease

Sponsors

Division of Infectious Disease Therapeutics, Department of Infectious Diseases and Microbiology, Kobe University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: People who come to infectious department in Kobe University Hospital. And physician think that vaccination is necessary and there is no contraindication for the vaccination.

Exclusion criteria

Exclusion criteria: People has contraindication for the vaccine and has previous history of Guillain-Barre syndrome

Design outcomes

Primary

MeasureTime frame
Ask the participants about adverse reactions and disease prevention.

Countries

Japan

Contacts

Public ContactGoh Ohji

Kobe University Hospital Infectious Disease

ohji@sanynet.ne.jp078-382-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026